Tenaya Therapeutics Announces AHA Late-Breaking TN-201 Data
Tenaya Therapeutics (NASDAQ: TNYA) announced two late-breaking oral presentations at…
Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025
Myriad Genetics, Inc. SALT LAKE CITY, July 29, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a…